Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 646

1.

A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.

Kozaka K, Sasaki M, Fujii T, Harada K, Zen Y, Sato Y, Sawada S, Minato H, Matsui O, Nakanuma Y.

Histopathology. 2007 Sep;51(3):390-400. Epub 2007 Jun 6.

PMID:
17553067
2.

The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.

Aishima S, Asayama Y, Taguchi K, Sugimachi K, Shirabe K, Shimada M, Sugimachi K, Tsuneyoshi M.

Mod Pathol. 2002 Nov;15(11):1181-90.

3.

The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.

Maeda T, Kajiyama K, Adachi E, Takenaka K, Sugimachi K, Tsuneyoshi M.

Mod Pathol. 1996 Sep;9(9):901-9.

PMID:
8878022
4.

Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver.

Morita D, Kagata Y, Ogata S, Tsuda H, Hatsuse K, Mochizuki H, Matsubara O.

Pathol Int. 2006 Apr;56(4):222-6.

PMID:
16634969
5.
6.

Coexpression of neural cell adhesion molecules and bcl-2 in intrahepatic cholangiocarcinoma originated from viral hepatitis: relationship to atypical reactive bile ductule.

Asayama Y, Aishima S, Taguchi K, Sugimachi K, Matsuura S, Masuda K, Tsuneyoshi M.

Pathol Int. 2002 Apr;52(4):300-6.

PMID:
12031086
7.
8.
9.

Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma.

Haas S, Gütgemann I, Wolff M, Fischer HP.

Am J Surg Pathol. 2007 Jun;31(6):902-6.

PMID:
17527078
10.

Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma.

Zimmerman RL, Fogt F, Burke M, Murakata LA.

Oncol Rep. 2002 Jul-Aug;9(4):689-92.

PMID:
12066193
11.

Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.

Shirakawa H, Kuronuma T, Nishimura Y, Hasebe T, Nakano M, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kobayashi N, Kinoshita T, Nakatsura T.

Int J Oncol. 2009 Mar;34(3):649-56.

PMID:
19212669
12.

Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.

Somorácz A, Tátrai P, Horváth G, Kiss A, Kupcsulik P, Kovalszky I, Schaff Z.

Hum Pathol. 2010 Sep;41(9):1310-9. doi: 10.1016/j.humpath.2009.10.029. Epub 2010 May 14.

PMID:
20471664
13.

Hepatocarcinoma-intestine-pancreas/pancreatic associated protein (HIP/PAP) is expressed and secreted by proliferating ductules as well as by hepatocarcinoma and cholangiocarcinoma cells.

Christa L, Simon MT, Brezault-Bonnet C, Bonte E, Carnot F, Zylberberg H, Franco D, Capron F, Roskams T, Bréchot C.

Am J Pathol. 1999 Nov;155(5):1525-33.

14.

Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.

Ramalho FS, Ramalho LN, Della Porta L, Zucoloto S.

J Gastroenterol Hepatol. 2006 Aug;21(8):1276-80.

PMID:
16872309
15.

α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.

Ikeda H, Sato Y, Yoneda N, Harada K, Sasaki M, Kitamura S, Sudo Y, Ooi A, Nakanuma Y.

Hum Pathol. 2012 Nov;43(11):1955-63. doi: 10.1016/j.humpath.2011.11.022. Epub 2012 Apr 17.

PMID:
22516245
16.

A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.

Wakasa T, Wakasa K, Shutou T, Hai S, Kubo S, Hirohashi K, Umeshita K, Monden M.

Hepatogastroenterology. 2007 Mar;54(74):508-13.

PMID:
17523309
17.

Sarcomatous cholangiocarcinoma.

Gupta K, Powari M, Dey P.

Diagn Cytopathol. 2003 Mar;28(3):168-9. No abstract available.

PMID:
12619101
18.

Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma.

Batmunkh E, Tátrai P, Szabó E, Lódi C, Holczbauer A, Páska C, Kupcsulik P, Kiss A, Schaff Z, Kovalszky I.

Hum Pathol. 2007 Oct;38(10):1508-15. Epub 2007 Jul 19.

PMID:
17640714
19.

Enhanced expression of basement-membrane-type heparan sulfate proteoglycan in tumor fibro-myxoid stroma of intrahepatic cholangiocarcinoma.

Sabit H, Tsuneyama K, Shimonishi T, Harada K, Cheng J, Ida H, Saku T, Saito K, Nakanuma Y.

Pathol Int. 2001 Apr;51(4):248-56.

PMID:
11350606
20.

Supplemental Content

Support Center